SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Solana is a high-performance Layer 1 blockchain designed for mass adoption by providing a fast, secure, and low-cost environment for decentralized applications. It distinguishes itself by scaling globally without the use of complex sharding or multiple layers, instead maintaining a single, unified ledger to avoid liquidity fragmentation. This architecture allows it to process thousands of transactions per second with sub-second finality, often at a cost of less than a penny per transaction.  The network operates on a unique hybrid model that combines Proof of Stake with an innovation called Proof of History, which functions as a decentralized clock to timestamp transactions. This system reduces the need for constant node communication, allowing the Sealevel engine to run non-conflicting smart contracts in parallel across multiple CPU cores. Further efficiency is gained through the Gulf Stream protocol, which reduces confirmation times by forwarding transactions to validators before the current block is finished.  Founded in 2017 by Anatoly Yakovenko, Solana is now supported by the Switzerland-based Solana Foundation and significant institutional investors like Andreessen Horowitz and Polychain Capital. The platform’s native token, SOL, serves as the primary currency for paying transaction fees, participating in network governance, and securing the system through staking.   Solana has also seen significant institutional adoption ranging from spot Solana ETFs to major partnerships including Visa's 2025 launch of USDC settlement on the network and the tokenization of public equity by firms like Galaxy Digital.

Solana

Solana is trending as traders closely monitor its consolidation, with the community actively discussing potential price breakouts and the potential for increased DeFi adoption. The conversation is also heavily driven by excitement surrounding niche meme tokens like UpDog, which are gaining traction within the ecosystem.

The Mullen Army Token originated from a dedicated community of retail investors who faced challenges in the traditional stock market. We united to create a cryptocurrency that embodies our principles and aspirations for a fair financial system.     We provide a platform for retail investors to engage in a transparent and fair financial market. Our efforts include grassroots marketing, community engagement, and educational content to empower our investors.

MullenArmy

The MULN CRYPTO community is aggressively rallying around the token, attempting to ignite a weekend pump by drawing parallels to its volatile history as a meme-driven asset. While some users are actively promoting it as a high-potential rotation play with a low market cap, vocal skeptics continue to dismiss the project as a repetitive scam echoing the controversial legacy of the associated EV company.

Dumb SEND IT

$DSIT is generating significant buzz as its active developer emphasizes a commitment to community-focused growth, including regular airdrops, locked liquidity, and upcoming website and charting updates. Holders are actively discussing the project's resilience following initial price volatility and are rallying around a 'Dumb SEND IT' culture while awaiting broader platform visibility to drive further momentum.

Far below the surface, where light no longer reaches and noise collapses into silence, the Sperm Whale endures.  It does not rely on speed or spectacle. It survives through mass, intelligence, and absolute awareness of its surroundings.  This project is shaped by the same principle — strength formed under pressure, movement guided by understanding, and conviction built where others cannot remain.  While the surface reacts, the deep decides.

The Sperm Whale

SPERMWHALE is experiencing intense trading activity as community members actively debate its potential for parabolic growth versus risks of extreme volatility. Investors are currently hyper-focused on the coin's momentum and the high-stakes culture of rotating profits between various micro-cap tokens.

Cadrenal Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in developing novel therapy. It develops tecarfarin, a novel therapy with orphan drug indication, designed for the prevention of systemic thromboembolism of cardiac origin in patients with end-stage renal disease and atrial fibrillation. The company was founded by Quang X. Pham and Matthew K. Szot on January 25, 2022 and is headquartered in Ponte Vedra, FL.

Cadrenal Therapeutics Inc

Cadrenal Therapeutics, Inc.

Cadrenal Therapeutics is gaining attention following the announcement of a preliminary design for the Phase 3 trial of its lead candidate, CAD-1005, aimed at treating Heparin-Induced Thrombocytopenia. While some community members are optimistic about the clinical advancement and the company's potential to address significant unmet needs in cardiovascular care, others are expressing skepticism, labeling the recent surge in social media activity as bot-driven spam.

🔥 COCK Token – The Ultimate Cross-Chain MemeFi Powerhouse 🔥  In just under 20 days, $COCK has smashed expectations, broken ATHs, and built a project that’s shaking up Cardano and the entire crypto space. 🐓 What Makes $COCK Special?      The Name: Love it or hate it, the energy and engagement it generates are undeniable. The nuance in language and wild appeal set us apart.     #MEMEFI Pioneer: We’re not just another meme coin. $COCK is leading a movement by combining DeFi mechanics, game theory, and community engagement into a groundbreaking ecosystem.     COCKARENA: At the core of our ecosystem is the COCKARENA, a PvP HODL game. Players battle it out, and early exit fees fuel redistributions, burns, and the treasury. This ensures price appreciation and long-term sustainability for loyal holders.  🎰 The COCK Casino  Our casino isn’t just fun—it’s a serious revenue stream for the FLOCK.      Games: Bonanza, Crash, Blackjack, and Roulette (coming soon!).     Impact: Over 7,834 ADA in profits generated within days, directly supporting rewards, burns, and reinvestment.  💰 COCK-ARENA Loans  Unlock liquidity without selling your tokens.      Loan Terms: Borrow up to 30% of your holdings while continuing to earn rewards in the arena.     Investor Focus: Perfect for savvy investors staying in the game while tapping into their holdings.  🤝 Our Insane Partnerships  We’re bridging gaps, building alliances, and breaking barriers across the crypto space. Key Partners:      DANZO: Powering #MEMEFI with Arena, Casino, and Loans.     KLENEK: Interactive training room.     HSKN (Charles Hoskilien): Supporting and starting COCKPIN with 115 AIR NODES for DePIN aggregation. Plans to add APEX and Earth Nodes through a crypto company incorporated in Costa Rica.     ELITE CATS / SNEKKIES / HOT / BANK: Rewarding NFT holders with COCK-LOCK tokens and vice versa.     OCKZ: COCKSOCKS, Golden Cock Ticket (1M COCK), airdrop rewards, and whitelist perks for holders of 200 ADA worth of $COCK.     OLI Partnership:         Content Creation: Lux and the team are crafting engaging educational content about memes and MemeFi for OLi's platform.         Strategic Investment: The OLi Community Trust will invest in $COCK, distributing 100% of rewards to $OLI holders.         Community Reach: Over 22,000 learners will discover $COCK through OLi's gamified ecosystem.     Hi-Rez the Rapper: Expanding reach in marketing and entertainment.     KUNO, CALEB, CADEN, FITY, ROVER, WhaleInsider: Influential collaborators driving crypto adoption and growth.     Cardano Girls: Helping us understand and communicate effectively with ADA’s female audience.     WallStreetBets: Breaking barriers and increasing engagement.     Antonio Brown: Endorsing, supporting, and even playing in the casino and arena!     Advisors:         BERIS, HECKTHESNEK, RTB, CRYPTOGENIUS: Trusted names advising and supporting the project.  Future Partnerships:  More collaborations are in the pipeline to continue expanding engagement and bring new eyes to ADA and CNTs. 🔥 Unmatched Results in Just 20 Days      Supply Burned: 1.65%, worth 148K ADA!     Arena Fees Collected: 54M COCK, worth over 500K ADA, fueling rewards, burns, and partnerships.     Staked COCK-LOCK: 11M COCK-LOCK in the liquid staking platform, with more coming.     Casino Revenue: Skyrocketing profits directly rewarding holders and growing the treasury.     Top Blast Contests: Generated over 120K ADA in volume, rewarding participants with over 50K ADA in prizes.  🌍 Our Vision  To be the most decentralized, rewarding, and innovative token on Cardano while fostering cross-chain collaboration and onboarding the masses.      Breaking Barriers: We’re bringing BTC, ETH, SOL, and other chains into the fold.     Community-Driven: Focused on building bridges and showcasing that crypto can be fun, rewarding, and sustainable.     Expansion: This is just the beginning. With more burns, rewards, and partnerships on the way, $COCK is set to redefine what’s possible in the MemeFi space.  💎 Time in the arena &gt; Timing the market. The FLOCK is unstoppable. Let’s keep breaking walls for Cardano and onboard new users as we take $COCK to new heights.

CockCardano

CockCardano is trending as the community highlights the project's real-world business integration through revenue-generating food truck events that fuel token buybacks. Investors are actively discussing the project's passive staking opportunities and its resilience within the Cardano ecosystem.

Injective is an interoperable Layer 1 blockchain designed for DeFi applications. It provides developers with on-chain financial infrastructure modules to build dApps such as decentralized exchanges, prediction markets, and lending protocols. Its decentralized cross-chain bridging infrastructure offers compatibility with most blockchains, including EVM chains like Ethereum and non-EVM chains like Solana.

Injective

The Injective ($INJ) ecosystem is capturing significant attention due to major institutional developments, including a $100 million treasury investment by Pineapple Financial and multiple ETF filings that signal long-term institutional adoption. Community discourse is heavily focused on the potential for asymmetric growth, with traders aggressively accumulating $INJ alongside the community-led meme coin $NONJA, which is increasingly viewed as a leveraged play on Injective's broader infrastructure expansion.

Baby Doge Coin is a meme cryptocurrency designed to be deflationary and more scarce over time. All holders of Baby Doge will earn more baby doge that is automatically sent to your wallet by simply holding Baby Doge coins in your wallet. Watch the amount of baby doge grow in your wallet as baby doge coin holders automatically receive a 5% fee from every on chain transaction that happens on the Baby Doge ecosystem. The community receives more baby doge coins from the fees generated each transaction.

Baby Doge Coin

Baby Doge Coin is seeing renewed market attention and strong community enthusiasm as holders speculate on potential listings at major US exchanges and anticipate a breakout. Investors are actively discussing accumulation strategies during market volatility while highlighting the coin's ecosystem utility and its historical connection to the broader meme sector.

Bankr is an advanced AI agent focused on simplifying the process of buying and selling digital assets. Bankr was the first AI agent on Farcaster to help you quickly buy all your favorites coins directly in the social. BankrCoin is the official coin of the agent and was deployed by Bankr itself directly in the Farcaster social feed. Fees from swaps go to support BankrCoin. Bankr is available on Farcaster and will soon be launching a private terminal, token recs, and limit orders on Base.

BankrCoin

BankrCoin is capturing market attention as its AI-integrated infrastructure and automated DeFi tools gain traction on the Base ecosystem. The community is actively discussing its potential for long-term utility and increased liquidity, with many investors viewing current price action as an accumulation phase.

What makes MOG an absolute game-changer is our relentless dedication to memes and viral brilliance! We don't settle for mediocrity; we plunge into the realm of sheer awesomeness! Our community is a powerhouse of meme warriors, unleashing an unstoppable onslaught of viral memes that'll leave you in awe and stitches!  We're not here to play games; we're here to dominate! MOG is all about pushing the boundaries, smashing through barriers, and leaving our competitors eating our dust! Our passion for humor burns like an inferno, and we won't rest until the entire internet bows down to our meme supremacy!  And our community? It's a brotherhood, an unyielding powerhouse of support and camaraderie! When you're part of MOG, you're part of an unstoppable force, a family forged by the fire of meme revolution!  So, if you're ready to be part of the most intense, mind-bending memecoin movement ever conceived, then buckle up, strap in, and brace yourself! MOG is here to claim the throne, and we're taking no prisoners! Get ready to witness meme history in the making!

 MOG Coin

MOG Coin is currently at the center of a polarized debate, with community members aggressively promoting its potential for significant gains while critics dismiss the asset as a persistent scam. Investors are closely monitoring the token's price action as part of broader meme coin market volatility and ongoing speculation surrounding future exchange listings and potential ETF filings.

statis crypto Watchlist

Bitcoin

Ethereum

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Legend Biotech Corporation Sponsored ADR (NASDAQ:LEGN) Receives Average Rating of "Moderate Buy" from Analysts

Shares of Legend Biotech Corporation Sponsored ADR (NASDAQ:LEGN - Get Free Report) have earned a consensus rating of "Moderate Buy" from the fifteen research firms that are currently covering the...

Legend Biotech Corporation Sponsored ADR $LEGN Stock Holdings Lowered by Matthews International Capital Management LLC

Matthews International Capital Management LLC reduced its holdings in Legend Biotech Corporation Sponsored ADR (NASDAQ:LEGN - Free Report) by 7.0% during the 4th quarter, according to its most recent...

Legend Biotech (LEGN) Moves 18.4% Higher: Will This Strength Last?

Legend Biotech (LEGN) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.

HC Wainwright Reaffirms "Buy" Rating for Legend Biotech (NASDAQ:LEGN)

HC Wainwright reiterated a "buy" rating and set a $50.00 price target on shares of Legend Biotech in a report on Tuesday...

Why Legend Biotech Stock Crushed the Market on Monday

Key PointsThis followed a sizable acquisition of a peer biotech by a pharmaceutical sector giant...

<ul class="summary-bullets"><li>Legend, like Kelonia, develops and manufactures cell therapies to treat life-threatening diseases, particularly cancer.</li><li>Legend is best known for Carvykti, a CAR-T treatment for relapsed or refractory multiple myeloma, developed and marketed in collaboration with Johnson &amp; Johnson.</li></ul>Shares of Legend Biotech (LEGN) closed 18% higher on Monday, its best day since April 2023, following Eli Lilly and Company’s (LLY) buyout of its rival Kelonia Therapeutics for up to $7 billion.Lilly said earlier in the day that it has entered into a definitive agreement to acquire Kelonia to advance CAR-T cell therapies. Kelonia's lead program, KLN-1010, is an in vivo CAR-T therapy currently in early-stage studies for relapsed/refractory multiple myeloma.Under the terms of the deal, Lilly will pay Ketonia shareholders an upfront payment of $3.25 billion in addition to milestone payments. The transaction is expected to close in the second half of 2026.Legend, like Kelonia, develops and manufactures cell therapies to treat life-threatening diseases, particularly cancer. It is best known for Carvykti, a CAR-T treatment for relapsed or refractory multiple myeloma, developed in collaboration with Johnson &amp; Johnson (JNJ).Last month, Legend said that more than 10,000 patients have been treated with Carvykti and that the franchise achieved profitability for the full year 2025. Carvykti net trade sales came in at $1.9 billion for the year.<h2 class="st-heading-2">Wall Street Takeaway</h2>Following the deal announcement, RBC Capital reportedly reiterated an ‘Outperform’ rating and $62.00 price target on Legend Biotech, opining that it highlights large pharma interest in the CAR-T market, according to a <a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://m.in.investing.com/news/stock-market-news/rbc-capital-reiterates-legend-biotech-stock-rating-on-pharma-interest-93CH-5346810?ampMode=1">report</a> from Investing.com. Legend has potential sales of $2.8 billion in 2026, according to RBC.H.C. Wainwright also reiterated a ‘Buy’ rating with a $50 price target citing progress across the company’s CAR-T therapy programs, as <a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://in.investing.com/news/stock-market-news/hc-wainwright-reiterates-legend-biotech-stock-rating-on-pipeline-progress-93CH-5345904">per</a> Investing. First-in-human data from the LUCAR-G39D in vivo cell therapy for relapsed/refractory B-cell non-Hodgkin lymphoma is expected to start rolling in during the second half of 2026, with Wainwright flagging ASCO 2026 conference in late May to in early June as a plausible venue for the first readout.According to data from Koyfin, 14 of 16 analysts covering LEGN rate it ‘Buy’ or higher while two rate it ‘Hold.’ The 12-month average price target on the stock is $57.23, presenting a potential upside of about 128% from last close.<h2 class="st-heading-2"> How Did Retail Traders React?</h2>On Stocktwits, retail sentiment around LEGN stayed within the ‘extremely bullish’ territory while message volume jumped from ‘high’ to ‘extremely high’ levels.A Stocktwits user sounded optimistic for Johnson &amp; Johnson acquiring Legend to “not split the revenue” with Carvykti.<stembedurl>https://www.stocktwits.com/Realtrader77/message/650805222</stembedurl>Another voiced optimism for the company getting bought out for $41/ per share, presenting significant upside.<stembedurl>https://www.stocktwits.com/Stockseeking/message/650804814</stembedurl><a href="https://stocktwits.com/symbol/LEGN">LEGN stock</a> has fallen 22% over the past 12 months.&nbsp;Read More: <a href="https://stocktwits.com/news-articles/markets/equity/jetblue-ceo-vows-strong-cash-pile-will-prevent-bankruptcy-in-2026-report/cZBdZIgRIzp">JetBlue CEO Vows Cash Pile Will Prevent Bankruptcy in 2026: Report</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

In this photo illustration, the Legend Biotech Corporation logo is seen displayed on a smartphone screen. (Photo Illustration by Thomas Fuller/SOPA Images/LightRocket via Getty Images)

LEGN Stock Clocks Best Day In Three Years — What’s Driving The Rally?

After Eli Lilly and Company bought Kelonia to advance CAR-T cell therapies, retail traders are now speculating a buyout for Legend. 

Equity

After Eli Lilly and Company bought Kelonia to advance CAR-T cell therapies, retail traders are now speculating a buyout for Legend. 


HC Wainwright Boosts Earnings Estimates for Legend Biotech

Legend Biotech Corporation Sponsored ADR (NASDAQ:LEGN - Free Report) - Research analysts at HC Wainwright increased their Q1 2026 earnings per share (EPS) estimates for Legend Biotech in a research...

Legend Biotech (NASDAQ:LEGN) Trading 6.3% Higher   - Still a Buy?

Legend Biotech (NASDAQ:LEGN) Trading 6.3% Higher - Here's What Happened...

Legend Biotech's (LEGN) Buy Rating Reaffirmed at HC Wainwright

HC Wainwright restated a "buy" rating and issued a $50.00 price target on shares of Legend Biotech in a research note on Wednesday...

Legend Biotech Corporation Sponsored ADR (NASDAQ:LEGN) Given Average Recommendation of "Moderate Buy" by Brokerages

Legend Biotech Corporation Sponsored ADR (NASDAQ:LEGN - Get Free Report) has been assigned an average rating of "Moderate Buy" from the fifteen research firms that are presently covering the company...

Legend Biotech Corp. is a clinical-stage biopharmaceutical company, which engages in the discovery, development, manufacturing, and commercialization of novel therapies for oncology and other indications. The firm develops advanced cell therapies across a diverse array of technology platforms, including autologous and allogeneic chimeric antigen receptor T-cell, gamma-delta T cell and natural killer cell-based immunotherapy. It operates through the following geographical segments: United States of America, China, and Other. The company was founded in 2014 and is headquartered in Somerset, NJ.

Fiscal Period	Estimated	Reported	Surprise	Result
Q1 '26	$0.01	--	--	N/A
Q4 '25	$0.04	-$0.08	-323.83%	MISSED
Q3 '25	-$0.07	-$0.11	-51.30%	MISSED
Q2 '25	-$0.12	-$0.34	-195.59%	MISSED
Q1 '25	-$0.21	-$0.27	-28.31%	MISSED

LEGN
Legend Biotech

Feed

News

Sentiment

Earnings

Fundamentals

Info

Upcoming Earnings: Q1 '26

Historical Earnings

Latest LEGN News

LEGNLegend Biotech